Article Details

FDA slaps AstraZeneca, Fibrogen with last-minute roxadustat AdCom, cuing another delay for ...

Retrieved on: 2021-03-03 15:56:15

Tags for this article:

Click the tags to see associated articles and topics

FDA slaps AstraZeneca, Fibrogen with last-minute roxadustat AdCom, cuing another delay for .... View article details on hiswai:

Excerpt

The FDA has sent a last-minute notification of an advisory committee review of FibroGen and AstraZeneca's first-in-class anemia candidate roxadustat, ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up